Kotak Institutional Equities Stays Negative on Vedanta Amid High Leverage Risks

Kotak Institutional Equities has reiterated its sell rating on diversified metals & mining company Vedanta Ltd, citing significant leverage concerns for the parent Vedanta Resources Ltd (VRL). In a note on Tuesday, Kotak trimmed the fair value estimate for Vedanta to Rs 200 per share from Rs 215 earlier. The stock is trading at around […]

Kotak Institutional ‘Cautiously Optimistic’ on Emerging Markets

Kotak Institutional Equities has laid out a cautiously optimistic view on emerging market (EM) equities in its latest strategy report, arguing that select countries could benefit from favorable demographics and improving economic fundamentals. However, EMs will need to manage risks from democracy and disruption to realize their long-term potential. India will hold a pivotal position […]

Even As China Stumbles, Indian Economy Shows No Signs Of A Slow Down

India’s manufacturing and services sector activity continued to expand at a robust pace in August 2022, as per the latest Purchasing Managers’ Index (PMI) data. The manufacturing PMI rose to 58.6 in August from 57.7 in July, while the services PMI moderated slightly to 60.1 from 62.3 in the previous month. Nevertheless, the strong PMI […]

Rising generic threat in India not reflected in Pharma valuations – Kotak Institutional

A new report by Kotak Institutional Equities suggests that investors may be underestimating the threat posed by generic drugs to the ‘branded generics’ business of leading Indian pharmaceutical companies. The report highlights that current implied valuations of around 30-40x FY2025 EPS for most major pharma firms assume a relatively benign 10-11% growth in the Indian […]

“Limited opportunities” to make money in Indian equity markets due to rich valuations – Kotak Sec

Opportunities for making money in the current equity markets in India are ‘limited’ given expensive valuations across sectors and potential risks of earnings-downgrades, Kotak Securities’ Private Client Group warned in its monthly update. “The future for the markets may not all be all rosy with headwinds arising also from international shores with the U.S. Fed […]

Indian equities can go higher, but money may shift to large-caps: Axis Securities

Even as worries of high valuation and rising interest rates in the US give pause to some investors, Axis Securities has reiterated its positive outlook on Indian equity markets in its latest report for September 2023. The broking arm of Axis Bank highlights that the structural trend for the market remains positive, however, it expects […]

Systematix puts a ‘buy’ on Pfizer India on drug strong pipeline

Equity research firm Systematix Institutional Equities has initiated coverage on pharmaceutical major Pfizer Ltd with a “Buy” rating and set a target price of Rs 4,954, indicating an upside potential of around 30% from current levels. The broking house said the recent slowdown in Pfizer Inc’s Indian subsidiary was due to temporary factors and its […]

Maruti Suzuki roars back, as SUV sales more than double in August

Maruti Suzuki Ltd, India’s largest auto maker, reported robust numbers for August, as it consolidated its recently acquired status as India’s top SUV maker. The company’s total vehicle sales for August rose 14.5% on the year to 1.89 lakh vehicles, led by strong sales of SUVs. The automaker, which recently launched the much-awaited 4-wheel drive […]

Screenwriter Kriti Kapoor to make directorial debut with ‘Sorry Not Sorry’

Screenwriter Kriti Kapoor, who has served as assistant director on films like ‘Airlift’, ‘2 States’, and ‘Blood Money’, is making her directorial debut with the film ‘Sorry Not Sorry’. The upcoming comedy-drama produced by Mohaan Nadaar’s Teamo Productions revolves around a small-town girl who gets caught up in the world of social media fame and […]

Brigade Ent to build new project on Pfizer land plot in Chennai

Brigade Enterprises said it has acquired a plot of Rs 139 crores from Pfizer Healthcare India Ltd in Chennai to build a residential project. The 6.54 acre land-plot has been acquired in Sholinganallur, on the Old Mahabalipuram Road. “We will be developing a residential project on this land parcel with an overall development of over […]

Market Outlook: Nifty 50 seen facing resistance at 18,000-18,200

An analysis of the futures & options trends indicate that NSE Nifty 50 index is expected to face resistance at around 18,000-18,200 points this week, and will find support between 17500-17300. With uncertainties around Fed, Budget and global economy persisting, traders appear wary of taking large bets. This implies rangebound action will likely continue into […]

Mid-Year Review: Top 10 stocks to watch out for in second half of 2023

While 2023 has been a wild ride for stock investors in India so far, market volatility doesn’t mean that there aren’t enough front-line stocks with interesting tales of their own this year. There are several stocks that could outperform on the back of strong fundamentals and growth drivers, from sectors ranging from lending, IT services, […]